A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

T Cells · Colorectal Cancer · Lynch Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Eduardo Vilar Sanchez, MD)
Contact: Principal Investigator (Eduardo Vilar Sanchez, MD)

Study leads

Eduardo Vilar-Sanchez, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Colorectal Cancer (CRC) · Tumor Infiltrating Lymphocytes · PD-1

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases

Colorectal Cancer · Metastatic Liver Cancer

Abroad (travel likely)RecruitingPHASE1

Shanghai, China